Health Sagimet’s Shares Hit New High as Fatty Liver Disease Drug Shows Promise in Study Posted on January 22, 2024 by miyuru (Reuters) -Sagimet Biosciences stated on Monday its speculative drug to deal with a fatty liver illness considerably decreased the signs in a mid-stage research study, sending out the drug maker’s….